Device / Technology News

RSS

GenSpera acquires patent application for medical imaging technology

GenSpera, Inc. announced that it has acquired a patent application from the Johns Hopkins University and the University of Copenhagen for technology relating to medical imaging. The technology incorporates derivatives of thapsigargin, the active ingredient in GenSpera's therapeutics program, coupled with its patented tumor-targeted peptides, to create cancer-specific imaging compounds.

4 Aug 2010

Invivo recognized with 2010 Gold Medical Design Excellence Award

On June 9, 2010, Invivo was recognized with a 2010 Gold Medical Design Excellence Award for its DynaCAD for Prostate and DynaTRIM (Trans-Rectal Interventional MRI) clinical solutions. The MDEA awards ceremony took place in early June at New York City's Jacob K. Javits Convention Center where gold and silver winners were honored.

4 Aug 2010

Definiens launches Tissue Studio 2.0 image analysis software for digital pathology

Definiens today announced the introduction of Definiens Tissue Studio™ 2.0, the latest version of the company's leading image analysis software for digital pathology.

4 Aug 2010

STAAR Surgical second-quarter total net revenue increases 3.7% to $13.6 million

STAAR Surgical Company, a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today reported results for the second quarter ended July 2, 2010. Revenue for the period grew 3.7% to $13.6 million with the revenue from core products, IOLs and ICLs, increasing by 7%. For the first half of 2010 core product revenues increased by 11% reflecting market share gains by STAAR.

4 Aug 2010

IL releases new HemosIL HIT-Ab(PF4-H) assay

Instrumentation Laboratory (IL) today announced the release of the new HemosIL HIT-Ab(PF4-H) assay as a European CE IVD Mark product under the European Directive on In Vitro Diagnostic Medical Devices. Delivering results in minutes, the HemosIL HIT-Ab(PF4-H) assay detects total immunoglobulin against Platelet Factor 4-Heparin complexes, the antibodies associated with the pathology of HIT.

4 Aug 2010

Bayer implements ValGenesis validation process management software at Berkeley and Emeryville sites

ValGenesis, Inc., a world-leading provider of Validation Lifecycle Management (VLM) software solutions, today announced that Bayer HealthCare AG has implemented ValGenesis software as their platform for validation process management at their Berkeley and Emeryville sites.

4 Aug 2010

Siteman Cancer Center to test radiotherapy system from ViewRay

Researchers at the Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, Missouri, a national leader in the early adoption and use of advanced treatments for cancer patients, will soon become the first in the world to test an innovative radiotherapy system from ViewRay, Inc. The ViewRay system is designed to improve the accuracy of cancer treatments through a combination of medical imaging and radiotherapy delivery.

4 Aug 2010

Merck-Chimie to commercialize CardioGenics' proprietary paramagnetic beads

CardioGenics Holdings Inc., developer of the ultra-sensitive QL Care™ Point-Of-Care (POC) analyzer and products for the immunoassay segment of the In-Vitro Diagnostics market, announced that CardioGenics Inc. and Merck Chimie S.A.S. have agreed on a plan to commercialize CardioGenics' proprietary paramagnetic beads, with shipments to Merck-Chimie's customers scheduled to start mid-September 2010.

4 Aug 2010

Proton therapy to treat patient’s tumor without compromising quality of life

The radiation oncologist's mantra is to deliver the maximum dose of radiation to the malignant tumor, while limiting damage to healthy surrounding tissue. In proton therapy, this balance is achieved by using proton particles, accelerated to nearly the speed of light, to mimic the shape of a tumor and effectively deposit their energy within the confines of it with sub-millimeter precision.

4 Aug 2010

Victory Pharma acquires assets of MiddleBrook Pharmaceuticals

Victory Pharma, Inc. today announced that it has completed the acquisition of substantially all of the assets of MiddleBrook Pharmaceuticals, Inc..

4 Aug 2010

Biomedical engineering professor receives patent for Electromagnetic Probe Device

The United States Patent Office has issued a patent to Dr. Mark DeCoster, associate professor of biomedical engineering at Louisiana Tech University, for his invention of an "Electromagnetic Probe Device" - an innovative technology developed at Louisiana Tech's Institute for Micromanufacturing.

4 Aug 2010

Researchers discover first combined device for probing, detecting DNA

DNA microarrays are one of the most powerful tools in molecular biology today. The devices, which can be used to probe biological samples and detect particular genes or genetic sequences, are employed in everything from forensic analysis to disease detection to drug development.

4 Aug 2010

GE and Intel create new health IT venture focused on home-based care

General Electric Co. and Intel Corp. announced Monday they will create a company to provide new medical technologies for the elderly and chronically ill.

4 Aug 2010

Spectrum Health selects Aternity FPI Platform for strategic end user experience management initiatives

Aternity Inc., the industry's technology leader in end user experience management solutions for Global 1000 enterprises, announced today that Spectrum Health, a not-for-profit health system in West Michigan that offers a full continuum of care that includes the Spectrum Health Hospital Group, has selected the Aternity Frontline Performance Intelligence (FPI) Platform for its strategic end user experience management initiatives.

4 Aug 2010

New algorithm to reduce radiation dose in CT imaging

In recent years, advances in CT scanner technology have made perfusion computed tomography (CT) imaging an important diagnostic tool for patients with suspected stroke. Now, researchers at Mayo Clinic are working to reduce radiation dosages used to acquire perfusion and other CT images. Mayo Clinic medical physicist Cynthia McCollough, Ph.D., and her group of researchers presented their findings related to CT dose reduction at the 52nd Annual Meeting of the American Association of Physicists in Medicine on July 20 in Philadelphia. The presentation was entitled "20-Fold Dose Reduction Using a Gradient Adaptive Bilateral Filter: Demonstration Using in Vivo Animal Perfusion CT."

4 Aug 2010

BARDA awards contract to develop Pfenex Expression Technology

Pfenex Inc. today announced that the Department of Health and Human Services (HHS), through the Biomedical Advanced Research and Development Authority (BARDA) has awarded Pfenex a contract providing for up to a total of $18.8 million in funding, provided that certain milestones are achieved and that all contract options and extensions are exercised by the government. The contract will support the development of a robust Pfenex Expression Technology based production strain and process for the production of bulk recombinant protective antigen (rPA) from anthrax.

4 Aug 2010

DTB launches Don't Drop Mixtard 30 campaign to change Novo Nordisk's drug removal decision

Drug company Novo Nordisk's decision to pull its Mixtard 30 insulin drug from the UK could add 9 million to the NHS drugs bill in England alone, says an editorial in the Drug and Therapeutics Bulletin (DTB). The decision could also leave thousands of patients dependent on others to help them take their insulin, says DTB, which today launches its "Don't Drop Mixtard 30" campaign to convince the company to change its mind.

4 Aug 2010

QCMG selects SGI LiveArc storage solution for cancer genome sequence data processing

SGI, a global leader in HPC and data center solutions, today announced that the Queensland Centre for Medical Genomics at the University of Queensland has selected SGI LiveArc storage solution to increase its ability to store, manage and process human cancer genome sequence data. This project will contribute to mapping the genetic changes that lead to cancer, providing better understanding of such cancers and potentially helping to combat the disease.

4 Aug 2010

ICU Medical's Neutron Neutral-Pressure Needleless Connector receives FDA clearance

ICU Medical, Inc., a worldwide leader in the development, manufacture and sale of proprietary, disposable medical connection systems for use in vascular therapy applications, today confirmed that it has received FDA 510-k clearance for the Neutron™ Neutral-Pressure Needleless Connector.

4 Aug 2010

Dendreon to implement Pilgrim's Deviation and Corrective and Preventive Action management system

Pilgrim Software, Inc., a world-leading provider of Enterprise Risk, Compliance and Quality Management (ERCQM) software solutions, today announced that Dendreon Corporation, a Seattle-based biotechnology company, will implement Pilgrim's automated system for Deviation and Corrective and Preventive Action (CAPA) management using its on-demand software as a service platform.

4 Aug 2010

Device / Technology News

GenSpera acquires patent application for medical imaging technology

Invivo recognized with 2010 Gold Medical Design Excellence Award

Definiens launches Tissue Studio 2.0 image analysis software for digital pathology

STAAR Surgical second-quarter total net revenue increases 3.7% to $13.6 million

IL releases new HemosIL HIT-Ab(PF4-H) assay

Bayer implements ValGenesis validation process management software at Berkeley and Emeryville sites

Siteman Cancer Center to test radiotherapy system from ViewRay

Merck-Chimie to commercialize CardioGenics' proprietary paramagnetic beads

Proton therapy to treat patient’s tumor without compromising quality of life

Victory Pharma acquires assets of MiddleBrook Pharmaceuticals

Biomedical engineering professor receives patent for Electromagnetic Probe Device

Researchers discover first combined device for probing, detecting DNA

GE and Intel create new health IT venture focused on home-based care

Spectrum Health selects Aternity FPI Platform for strategic end user experience management initiatives

New algorithm to reduce radiation dose in CT imaging

BARDA awards contract to develop Pfenex Expression Technology

DTB launches Don't Drop Mixtard 30 campaign to change Novo Nordisk's drug removal decision

QCMG selects SGI LiveArc storage solution for cancer genome sequence data processing

ICU Medical's Neutron Neutral-Pressure Needleless Connector receives FDA clearance

Dendreon to implement Pilgrim's Deviation and Corrective and Preventive Action management system

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News